68Ga-DOTA-NT-20.3. An innovative probe for neurotensin receptor-positive tumor imaging in the diagnosis of malignant pleural mesothelioma

M. Marenco (Pavia, Italy), V. Frangipane (Pavia, Italy), M. Hodolic (Graz, Austria), S. Inghilleri (Pavia, Italy), G. Stella (Pavia, Italy), F. Meloni (Pavia, Italy), L. Lodola (Pavia, Italy)

Source: International Congress 2018 – Pleural disease: diagnosis, monitoring and management
Session: Pleural disease: diagnosis, monitoring and management
Session type: Oral Presentation
Number: 499
Disease area: Thoracic oncology

Congress or journal article abstractWebcastSlide presentationE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Marenco (Pavia, Italy), V. Frangipane (Pavia, Italy), M. Hodolic (Graz, Austria), S. Inghilleri (Pavia, Italy), G. Stella (Pavia, Italy), F. Meloni (Pavia, Italy), L. Lodola (Pavia, Italy). 68Ga-DOTA-NT-20.3. An innovative probe for neurotensin receptor-positive tumor imaging in the diagnosis of malignant pleural mesothelioma. 499

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The radiologic evidance in distinguishing the pleural mesothelioma from the pleural metastatic adenocarcinoma
Source: Eur Respir J 2006; 28: Suppl. 50, 93s
Year: 2006

Thoracoscopy in malignant pleural effusions secondary to breast cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 611s
Year: 2006

Multimodality therapy for malignant pleural mesothelioma
Source: Eur Respir J 2004; 24: Suppl. 48, 526s
Year: 2004

Medical thoracoscopy: hormone receptor content in pleural metastases due to breast cancer
Source: Eur Respir J 2004; 24 : 728-730
Year: 2004



Multimodal therapy in malignant pleural mesothelioma (MPM)
Source: Eur Respir J 2002; 20: Suppl. 38, 187s
Year: 2002

Bevacizumab-targeted therapy for malignant pleural mesothelioma
Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs
Year: 2017


Diagnosis and staging of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

PET predicts survival in malignant pleural mesothelioma
Source: ISSN=ISSN 1810-6838, ISBN=, page=290
Year: 2007

Biochemical and cytological features of metastatic pleural effusions in breast cancer
Source: Eur Respir J 2007; 30: Suppl. 51, 671s
Year: 2007

A case report: surprising diagnosis of malignant mesothelioma in a patient with malignant pleural effusion, mediastinal lymphoma and intestinal carcinoma in situ
Source: Eur Respir J 2004; 24: Suppl. 48, 527s
Year: 2004

Integrated CT-PET is a valuable tool for staging malignant pleural mesothelioma
Source: ISSN=ISSN 1810-6838, ISBN=, page=173
Year: 2005

Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma
Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours
Year: 2008


Three dimensional evaluation of chemotherapy response in malign pleural mesothelioma
Source: Eur Respir J 2007; 30: Suppl. 51, 754s
Year: 2007

The impact of multimodal treatment approaches in patients with malignant pleural mesothelioma
Source: Annual Congress 2010 - Diagnostic and therapeutic problems in surgical oncology
Year: 2010


An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma
Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis
Year: 2006


Pre-therapeutic staging and prognostic factors in malignant pleural mesothelioma patients
Source: Annual Congress 2009 - Malignant pleural mesothelioma guidelines
Year: 2009


Pathological diagnosis of malignant pleural mesothelioma
Source: ERS Online Course 2020: Calendar sheets in malignant pleural diseases
Year: 2020

Evaluation of response to chemotherapy for malignant pleural mesothelioma and suggestion of a new method
Source: Eur Respir J 2002; 20: Suppl. 38, 272s
Year: 2002

Identification of hormone receptors and HER-2 in samples of mediastinal nodal metastases of breast carcinoma obtained through endobronchial ultrasound
Source: Annual Congress 2013 –TBNA, EBUS-TBNA and new technologies for diagnostic bronchoscopy
Year: 2013